Revium Rx. (RVRC)
OTCMKTS · Delayed Price · Currency is USD
1.670
0.00 (0.00%)
Apr 20, 2026, 4:00 PM EST

Revium Rx. Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2009
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '09
Net Income
-13.45-3.51-0.99-1.21-0.1
Depreciation & Amortization
0.01000-
Asset Writedown & Restructuring Costs
9.68----
Stock-Based Compensation
0.6220.210.29-
Other Operating Activities
0.37-0-0.060
Change in Accounts Receivable
----0.27
Change in Inventory
----0.46
Change in Accounts Payable
0.020.03-0.26-00.07
Change in Other Net Operating Assets
0.220.270.030.042.53
Operating Cash Flow
-2.53-1.21-1.01-0.823.23
Capital Expenditures
-0.01-0-0-0-
Sale of Property, Plant & Equipment
----2
Cash Acquisitions
-0.73---
Investment in Securities
0.98-2-0.01--
Other Investing Activities
-0.03----
Investing Cash Flow
0.94-1.27-0.01-02
Long-Term Debt Repaid
-----0.11
Net Debt Issued (Repaid)
-----0.11
Issuance of Common Stock
-01.590.38-
Repurchase of Common Stock
-----0.01
Other Financing Activities
---0.2--5.13
Financing Cash Flow
-01.390.38-5.25
Net Cash Flow
-1.59-2.480.37-0.45-0.02
Free Cash Flow
-2.54-1.21-1.02-0.823.23
Free Cash Flow Margin
----491.85%
Free Cash Flow Per Share
-0.04-0.05-0.04-0.0355.51
Levered Free Cash Flow
-0.950.3-0.66-0.18
Unlevered Free Cash Flow
-0.950.3-0.66-0.18
Change in Working Capital
0.240.3-0.230.043.34
Source: S&P Global Market Intelligence. Standard template. Financial Sources.